The European Union is discussing how to finance a sharp increase in its defence readiness to deter any possible future attack from Russia and become less dependent for security on the United States. With the European Commission estimating EU defence spending needs at 500 billion euros ($523 billion) over the next 10 years,

Europêche, Europe’s fishing industry representative body, has praised the European Commission’s (EC) upcoming Omnibus Simplification Package, announced by EC President Ursula Von der Leyen on 25 February.

How can the European Commission’s Vision for Agriculture and Food report make a positive change in Europe's food and farming, a summary.

A leaked draft from the European Commission suggests Brussels will “immediately engage” with LNG suppliers to stabilize energy prices, all while still pretending it’s on track to kiss fossil fuels goo

A dozen leaders from Europe and Canada are in Ukraine’s capital to mark the third anniversary of Russia’s invasion. The visitors, including European Commission President Ursula von der Leyen and

Despite pressure from the U.S., the European Commission won’t delay antitrust actions against Apple and Meta. The European Union’s competition chief told Reuters that U.S. President Donald Trump has upended the “trustful relationship” between the United States and Europe,

The European Commission on Wednesday proposed making 100 billion euros ($105 billion) available to support EU-made clean manufacturing, streamlining public procurement processes and simplifying state aid rules to give Europe's ailing industries a boost.

The European Commission plans to loosen its rules on corporate sustainability reporting and supply chain transparency, it said on Wednesday, in a bid to make Europe more competitive with the United States and China.

Europe's Socialists and Democrats group rejects any change to supply chain due diligence rules, according to a letter to the European Commission president.

A European Commission committee is recommending AbbVie's Rinvoq for treatment of giant cell arteritis following phase 3 clinical trial results that showed efficacy and safety in the inflammatory disease.